Phase-aware development
Development strategies designed to evolve as process, dose and study requirements become more demanding.
Plan for early Phase II
Completing Phase I is an important milestone, but the transition into early Phase II brings new demands.
While a previous API-in-capsule approach may have supported your early clinical studies, further progress may require more complete formulation and process development, including strategies to address solubility and bioavailability.
Operational complexity.
We help you prepare your HP-OSD program for early Phase II with integrated development, manufacturing, packaging and clinical supply strategies supporting progression and reducing operational complexity.
Phase II asks bigger questions....
The knowledge gained during Phase I is only valuable if it's translated into stronger processes for the next stage. Planning early for Phase II will avoid unnecessary pressure across manufacturing, packaging and supply functions.
- Can your process scale?
- Will packaging become more complex?
- Can supply keep up with a broader program?
Strengthen. Prepare. Connect.
Improve process robustness before increasing batch sizes, dose strengths and operational expectations.
Plan for titration studies, multiple SKUs and increasingly complex labelling requirements without adding unnecessary operational burden.
Align development, packaging and clinical supply decisions early to reduce friction as your program progresses into early Phase II
Progress with what you've learned.
As programs move into early Phase II, manufacturing, analytical methods and packaging requirements often evolve at different speeds. We help you connect decisions and harmonize early to reduce complexity and create a more flexible platform for the next stage of development.
Today’s Phase I. Inspired by tomorrow.
Integrated packaging and supply
Packaging and clinical supply planned together to support increasingly complex study requirements.
Built for program progression
Connected planning that helps create flexibility for the demands of later development phases
Connect with a PCI specialist today to explore integrated development, manufacturing, packaging and clinical supply planning for Phase II.